These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: 11-Dehydro thromboxane B2: a reliable parameter of thromboxane A2 production in dogs.
    Author: Yamanaka S, Miura K, Yukimura T, Yamamoto K.
    Journal: Prostaglandins; 1993 Mar; 45(3):221-8. PubMed ID: 8484010.
    Abstract:
    Plasma concentration of 11-dehydro thromboxane B2 (TxB2) is reported to be a reliable indicator of TxA2 production in human and rabbit. The purpose of this study is to examine whether we can use this parameter in dogs. The plasma concentration of 11-dehydro TxB2 was determined by enzyme immunoassay method using anti-11-dehydro TxB2 monoclonal antibody. When 10 micrograms/kg of TxB2 was intravenously administered to dogs in which endogenous production of prostanoids was blocked by aspirin, the plasma concentrations of 11-dehydro TxB2 before and 2, 5, 15, 60 min after TxB2 administration were 6.2 +/- 1.4, 54.2 +/- 5.0, 65.2 +/- 14.3, 65.2 +/- 16.4 and 31.0 +/- 7.5 pg/ml, while the corresponding TxB2 levels were 20.1 +/- 3.1, 3143.3 +/- 379.5, 1432.6 +/- 120.5, 356.8 +/- 38.9, and 128.9 +/- 13.6 pg/ml, respectively. Platelet-activating factor (PAF, 0.5 micrograms/kg) induced pulmonary vasoconstriction which was blocked by aspirin and OKY-046 (TxA2 synthetase inhibitor), indicating that TxA2 mediated this change. Plasma concentration of 11-dehydro TxB2 was increased by PAF. This change was also blocked by aspirin and OKY-046. These data suggest that the determination of plasma concentration of 11-dehydro TxB2 is useful to estimate the in vivo production of TxA2 in dogs.
    [Abstract] [Full Text] [Related] [New Search]